Eli Lilly's Oral GLP-1 Treatment for Obesity on Track for Global Regulatory Submissions
27 Aug 2025
#eli_lilly #obesity #pharmaceutical #healthcare
Learn about Eli Lilly's successful Phase 3 trial for orforglipron as a treatment for obesity and its potential impact on the pharmaceutical company and healthcare industry.
